Liquidia Corporation
NasdaqCM:LQDA
Sector
Industries
Location
Market Cap
USD 2.33 B
Share Price
USD 27.11
Avg Daily Volume
2,821,451
Change (1 day)
-2.20%
Change (1 year)
176.91%
Change (YTD)
130.53%
Liquidia Corporation Cash Flow Statement 2017 - 2025
This table shows the Cash Flow Statement for Liquidia Corporation going from 2017 until 2025. The cash flow statement is a financial statement that shows the inflow and outflow of cash and cash equivalents from a company's operating, investing, and financing activities over a specified period. It provides crucial information about a company's ability to generate and manage cash, which is essential for its day-to-day operations, investments, and debt obligations.
Cash Flow Statement
| Annual data in millions of USD, except per share data | Trend |
|---|
Competitors
Eli Lilly and Company
USD 703.21
LLY
+5.16
0.74%
AbbVie Inc.
USD 206.19
ABBV
-0.38
-0.18%
Roche Holding AG
USD 337.32
RO.SW
+4.54
1.36%
Novo Nordisk A/S
USD 54.16
NOVO-B.CO
-0.02
-0.03%
Novartis AG
USD 124.85
NOVN.SW
+0.78
0.63%
AstraZeneca PLC
USD 150.15
AZN.L
-2.01
-1.32%
Abbott Laboratories
USD 131.25
ABT
+0.98
0.75%
Merck & Co., Inc.
USD 84.93
MRK
+0.71
0.84%
Thermo Fisher Scientific Inc.
USD 498.29
TMO
+10.75
2.21%
Amgen Inc.
USD 295.55
AMGN
+2.93
1.00%
Gilead Sciences, Inc.
USD 117.98
GILD
-0.01
-0.01%
Pfizer Inc.
USD 25.32
PFE
+0.25
1.00%
Sanofi
USD 100.73
SAN.PA
+0.93
0.94%
Vertex Pharmaceuticals Incorporated
USD 390.76
VRTX
+0.88
0.23%
Bristol-Myers Squibb Company
USD 48.34
BMY
+0.15
0.31%